Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils ID1237

In development
Reference number: GID-TA10239
Expected publication date: 06 August 2026

Register as a stakeholder

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 125 KB)

Published:

03 September 2025
Final stakeholder list (PDF 129 KB)

Published:

03 September 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 328 KB)

Published:

03 September 2025
Equality impact assessment (scoping) (PDF 112 KB)

Published:

03 September 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 1237

Draft matrix post referral (PDF 101 KB)

Published:

02 May 2025
Draft scope post referral (PDF 103 KB)

Published:

02 May 2025

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 308 KB)

Published:

27 September 2017
Draft matrix pre referral (PDF 257 KB)

Published:

27 September 2017